Replimune (REPL) EBT (2017 - 2026)
Replimune's EBT was -$68.87 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$87.18 million a year earlier.
Powered by 
Analysis
Replimune (REPL) EBT (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's EBT was -$295.65 million through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$314.49 million.
- In earlier fiscal years, EBT was -$246.83 million in FY2025, -$215.39 million in FY2024, -$174 million in FY2023 and -$118.04 million in FY2022.
- The fiscal Q1 2027 figure marks the highest quarterly EBT since fiscal Q3 2025.
- Per Business Quant data, REPL's EBT in the three fiscal quarters before Q1 2027 was -$73.46 million (Q4 2026), -$71.24 million (Q3 2026) and -$82.08 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | -68.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.87 Mn |
| Mar 31, 2026 | -73.46 Mn |
| Dec 31, 2025 | -71.24 Mn |
| Sep 30, 2025 | -82.08 Mn |
| Jun 30, 2025 | -87.18 Mn |
| Mar 31, 2025 | -74.24 Mn |
| Dec 31, 2024 | -65.77 Mn |
| Sep 30, 2024 | -53.06 Mn |
| Jun 30, 2024 | -53.77 Mn |
| Mar 31, 2024 | -55.14 Mn |
| Dec 31, 2023 | -50.65 Mn |
| Sep 30, 2023 | -60.25 Mn |
| Jun 30, 2023 | -49.35 Mn |
| Mar 31, 2023 | -48.95 Mn |
| Dec 31, 2022 | -39.69 Mn |
| Sep 30, 2022 | -43.10 Mn |
| Jun 30, 2022 | -42.25 Mn |
| Mar 31, 2022 | -31.86 Mn |
| Dec 31, 2021 | -29.61 Mn |
| Sep 30, 2021 | -29.17 Mn |
API Access
Replimune EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();